MRK logo

Merck & Co (MRK) EBIT

annual EBIT:

$20.22B+$17.19B(+566.26%)
December 1, 2024

Summary

  • As of today (April 13, 2025), MRK annual earnings before interest & taxes is $20.22 billion, with the most recent change of +$17.19 billion (+566.26%) on December 1, 2024.
  • During the last 3 years, MRK annual EBIT has risen by +$5.54 billion (+37.70%).
  • MRK annual EBIT is now at all-time high.

Performance

MRK EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

quarterly EBIT:

$4.35B-$73.00M(-1.65%)
December 1, 2024

Summary

  • As of today (April 13, 2025), MRK quarterly earnings before interest & taxes is $4.35 billion, with the most recent change of -$73.00 million (-1.65%) on December 1, 2024.
  • Over the past year, MRK quarterly EBIT has stayed the same.
  • MRK quarterly EBIT is now -63.70% below its all-time high of $11.98 billion, reached on December 31, 2014.

Performance

MRK quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

TTM EBIT:

$21.06B+$6.08B(+40.63%)
December 1, 2024

Summary

  • As of today (April 13, 2025), MRK TTM earnings before interest & taxes is $21.06 billion, with the most recent change of +$6.08 billion (+40.63%) on December 1, 2024.
  • Over the past year, MRK TTM EBIT has stayed the same.
  • MRK TTM EBIT is now at all-time high.

Performance

MRK TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

MRK EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+566.3%0.0%0.0%
3 y3 years+37.7%0.0%0.0%
5 y5 years+150.8%0.0%0.0%

MRK EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+566.3%-31.2%+185.9%at high+593.8%
5 y5-yearat high+566.3%-31.2%+185.9%at high+593.8%
alltimeall timeat high+2438.1%-63.7%+185.9%at high+2570.4%

Merck & Co EBIT History

DateAnnualQuarterlyTTM
Dec 2024
$20.22B(+566.3%)
$4.35B(-1.7%)
$21.06B(+40.6%)
Sep 2024
-
$4.42B(-30.0%)
$14.97B(-9.2%)
Jun 2024
-
$6.32B(+5.7%)
$16.49B(+222.3%)
Mar 2024
-
$5.97B(-444.1%)
$5.12B(+68.6%)
Dec 2023
$3.04B(-82.6%)
-$1.74B(-129.2%)
$3.04B(-64.4%)
Sep 2023
-
$5.94B(-217.4%)
$8.52B(+32.9%)
Jun 2023
-
-$5.06B(-230.0%)
$6.41B(-60.4%)
Mar 2023
-
$3.89B(+3.8%)
$16.19B(-7.0%)
Dec 2022
$17.41B(+18.5%)
$3.75B(-2.1%)
$17.41B(-2.1%)
Sep 2022
-
$3.83B(-19.0%)
$17.78B(-8.4%)
Jun 2022
-
$4.73B(-7.4%)
$19.41B(+16.9%)
Mar 2022
-
$5.10B(+23.9%)
$16.60B(+13.1%)
Dec 2021
$14.69B(+119.4%)
$4.12B(-24.6%)
$14.69B(+78.4%)
Sep 2021
-
$5.46B(+184.6%)
$8.23B(+45.0%)
Jun 2021
-
$1.92B(-39.8%)
$5.68B(-15.4%)
Mar 2021
-
$3.19B(-236.3%)
$6.71B(-11.4%)
Dec 2020
$6.69B(-17.0%)
-$2.34B(-180.4%)
$7.57B(-12.2%)
Sep 2020
-
$2.91B(-1.4%)
$8.63B(+4.0%)
Jun 2020
-
$2.95B(-27.2%)
$8.29B(-6.1%)
Mar 2020
-
$4.05B(-415.7%)
$8.84B(+9.6%)
Dec 2019
$8.06B(-14.9%)
-$1.28B(-149.8%)
$8.06B(-33.7%)
Sep 2019
-
$2.58B(-26.2%)
$12.15B(-2.2%)
Jun 2019
-
$3.49B(+6.6%)
$12.43B(+10.8%)
Mar 2019
-
$3.28B(+16.7%)
$11.22B(+18.4%)
Dec 2018
$9.47B(+30.2%)
$2.81B(-1.7%)
$9.47B(+8.4%)
Sep 2018
-
$2.85B(+25.2%)
$8.73B(+39.3%)
Jun 2018
-
$2.28B(+49.0%)
$6.27B(-5.3%)
Mar 2018
-
$1.53B(-26.1%)
$6.62B(-9.0%)
Dec 2017
$7.28B(+35.9%)
$2.07B(+431.9%)
$7.28B(+80.5%)
Sep 2017
-
$389.00M(-85.2%)
$4.03B(-39.8%)
Jun 2017
-
$2.63B(+20.5%)
$6.70B(+16.7%)
Mar 2017
-
$2.19B(-285.8%)
$5.74B(+7.3%)
Dec 2016
$5.35B(-11.9%)
-$1.18B(-138.5%)
$5.35B(-28.8%)
Sep 2016
-
$3.06B(+82.5%)
$7.51B(+7.1%)
Jun 2016
-
$1.68B(-6.7%)
$7.02B(+11.0%)
Mar 2016
-
$1.80B(+82.3%)
$6.32B(+4.1%)
Dec 2015
$6.07B(-66.3%)
$985.00M(-61.6%)
$6.07B(-64.4%)
Sep 2015
-
$2.56B(+161.2%)
$17.06B(+5.4%)
Jun 2015
-
$981.00M(-36.5%)
$16.18B(-6.4%)
Mar 2015
-
$1.54B(-87.1%)
$17.28B(-4.1%)
Dec 2014
$18.02B(+183.9%)
$11.98B(+612.4%)
$18.02B(+141.3%)
Sep 2014
-
$1.68B(-19.1%)
$7.46B(-0.8%)
Jun 2014
-
$2.08B(-8.8%)
$7.52B(+9.2%)
Mar 2014
-
$2.28B(+59.8%)
$6.89B(+8.6%)
Dec 2013
$6.35B(-32.9%)
$1.43B(-18.0%)
$6.35B(-1.5%)
Sep 2013
-
$1.74B(+20.3%)
$6.44B(-9.2%)
Jun 2013
-
$1.45B(-16.6%)
$7.10B(-16.5%)
Mar 2013
-
$1.73B(+13.8%)
$8.51B(-10.0%)
Dec 2012
$9.45B(+17.7%)
$1.52B(-36.4%)
$9.45B(-2.4%)
Sep 2012
-
$2.40B(-16.0%)
$9.68B(-1.3%)
Jun 2012
-
$2.85B(+6.3%)
$9.82B(+11.5%)
Mar 2012
-
$2.68B(+52.9%)
$8.81B(+9.5%)
Dec 2011
$8.03B(+239.1%)
$1.75B(-30.6%)
$8.04B(+39.6%)
Sep 2011
-
$2.53B(+37.2%)
$5.76B(+47.6%)
Jun 2011
-
$1.84B(-3.8%)
$3.90B(+11.9%)
Mar 2011
-
$1.92B(-464.8%)
$3.49B(+47.2%)
Dec 2010
$2.37B(-85.0%)
-$525.00M(-178.2%)
$2.37B(-75.1%)
Sep 2010
-
$671.00M(-52.9%)
$9.53B(-32.3%)
Jun 2010
-
$1.43B(+78.9%)
$14.06B(-4.4%)
Mar 2010
-
$797.00M(-88.0%)
$14.70B(-6.6%)
Dec 2009
$15.75B(+54.7%)
$6.63B(+27.4%)
$15.75B(+41.5%)
Sep 2009
-
$5.21B(+152.0%)
$11.13B(+49.7%)
Jun 2009
-
$2.07B(+12.1%)
$7.44B(-1.0%)
Mar 2009
-
$1.84B(-8.4%)
$7.51B(-26.2%)
Dec 2008
$10.18B(+81.3%)
$2.01B(+33.0%)
$10.18B(+4.3%)
Sep 2008
-
$1.51B(-29.3%)
$9.77B(+3.7%)
Jun 2008
-
$2.14B(-52.6%)
$9.42B(+8.0%)
Mar 2008
-
$4.52B(+182.8%)
$8.72B(+55.3%)
Dec 2007
$5.62B(+52.4%)
$1.60B(+37.1%)
$5.62B(+29.8%)
Sep 2007
-
$1.16B(-19.4%)
$4.33B(+16.5%)
Jun 2007
-
$1.44B(+2.4%)
$3.71B(+0.7%)
Mar 2007
-
$1.41B(+361.0%)
$3.69B(+0.0%)
Dec 2006
$3.69B(-37.1%)
$306.20M(-44.4%)
$3.69B(-18.3%)
Sep 2006
-
$550.30M(-61.2%)
$4.51B(-17.3%)
Jun 2006
-
$1.42B(+0.7%)
$5.45B(-3.3%)
Mar 2006
-
$1.41B(+24.8%)
$5.64B(-3.9%)
Dec 2005
$5.86B(-13.3%)
$1.13B(-24.4%)
$5.87B(+0.1%)
Sep 2005
-
$1.49B(-6.9%)
$5.86B(-0.1%)
Jun 2005
-
$1.60B(-2.1%)
$5.87B(-10.0%)
Mar 2005
-
$1.64B(+45.6%)
$6.52B(-3.5%)
Dec 2004
$6.76B
$1.13B(-25.0%)
$6.76B(-9.8%)
Sep 2004
-
$1.50B(-33.4%)
$7.49B(-11.1%)
DateAnnualQuarterlyTTM
Jun 2004
-
$2.26B(+20.3%)
$8.43B(+1.6%)
Mar 2004
-
$1.87B(+0.8%)
$8.30B(-3.0%)
Dec 2003
$8.57B(-5.7%)
$1.86B(-23.7%)
$8.56B(-7.2%)
Sep 2003
-
$2.44B(+14.8%)
$9.22B(+1.1%)
Jun 2003
-
$2.12B(-0.5%)
$9.12B(-2.5%)
Mar 2003
-
$2.14B(-15.4%)
$9.35B(-0.1%)
Dec 2002
$9.09B(-2.0%)
$2.52B(+7.9%)
$9.36B(+4.6%)
Sep 2002
-
$2.34B(-0.8%)
$8.95B(-3.2%)
Jun 2002
-
$2.36B(+10.0%)
$9.24B(-0.1%)
Mar 2002
-
$2.14B(+1.6%)
$9.26B(-0.2%)
Dec 2001
$9.28B(+2.1%)
$2.11B(-20.1%)
$9.28B(-2.8%)
Sep 2001
-
$2.64B(+11.4%)
$9.55B(+2.4%)
Jun 2001
-
$2.37B(+9.4%)
$9.32B(+0.7%)
Mar 2001
-
$2.16B(-9.0%)
$9.26B(+1.8%)
Dec 2000
$9.09B(+19.7%)
$2.38B(-1.3%)
$9.09B(+4.1%)
Sep 2000
-
$2.41B(+4.9%)
$8.73B(+5.4%)
Jun 2000
-
$2.30B(+15.1%)
$8.29B(+5.0%)
Mar 2000
-
$2.00B(-1.3%)
$7.89B(+3.9%)
Dec 1999
$7.59B(+19.1%)
$2.02B(+3.1%)
$7.59B(+3.4%)
Sep 1999
-
$1.96B(+3.2%)
$7.34B(+4.1%)
Jun 1999
-
$1.90B(+11.7%)
$7.05B(+5.4%)
Mar 1999
-
$1.70B(-4.0%)
$6.69B(+4.9%)
Dec 1998
$6.38B(+8.7%)
$1.77B(+6.1%)
$6.38B(+1.7%)
Sep 1998
-
$1.67B(+8.7%)
$6.27B(+4.3%)
Jun 1998
-
$1.54B(+10.6%)
$6.01B(+1.1%)
Mar 1998
-
$1.39B(-16.6%)
$5.95B(+1.5%)
Dec 1997
$5.86B(+17.6%)
$1.67B(+17.9%)
$5.86B(+6.4%)
Sep 1997
-
$1.42B(-4.1%)
$5.51B(+2.2%)
Jun 1997
-
$1.48B(+13.1%)
$5.39B(+3.7%)
Mar 1997
-
$1.30B(-1.0%)
$5.20B(+4.4%)
Dec 1996
$4.98B(+13.2%)
$1.32B(+1.7%)
$4.98B(+4.8%)
Sep 1996
-
$1.30B(+1.0%)
$4.76B(+2.8%)
Jun 1996
-
$1.28B(+18.2%)
$4.63B(+2.7%)
Mar 1996
-
$1.09B(-0.3%)
$4.51B(+2.3%)
Dec 1995
$4.40B(-0.0%)
$1.09B(-6.5%)
$4.40B(+1.1%)
Sep 1995
-
$1.17B(+0.2%)
$4.36B(-0.0%)
Jun 1995
-
$1.16B(+18.1%)
$4.36B(-0.9%)
Mar 1995
-
$985.10M(-5.6%)
$4.40B(-0.2%)
Dec 1994
$4.41B(+13.4%)
$1.04B(-10.5%)
$4.41B(-14.3%)
Sep 1994
-
$1.17B(-3.0%)
$5.14B(+3.2%)
Jun 1994
-
$1.20B(+21.0%)
$4.98B(+24.8%)
Mar 1994
-
$993.20M(-44.1%)
$3.99B(+2.6%)
Dec 1993
$3.89B(+11.3%)
$1.78B(+76.5%)
$3.89B(+32.0%)
Sep 1993
-
$1.01B(+373.8%)
$2.94B(+4.0%)
Jun 1993
-
$212.40M(-76.1%)
$2.83B(-20.3%)
Mar 1993
-
$890.30M(+6.7%)
$3.55B(+1.7%)
Dec 1992
$3.49B(+12.3%)
$834.40M(-6.5%)
$3.49B(+1.4%)
Sep 1992
-
$892.80M(-4.2%)
$3.44B(+3.1%)
Jun 1992
-
$931.70M(+11.9%)
$3.34B(+3.6%)
Mar 1992
-
$832.60M(+6.1%)
$3.22B(+3.6%)
Dec 1991
$3.11B(+17.3%)
$784.50M(-0.7%)
$3.11B(+3.5%)
Sep 1991
-
$790.40M(-2.9%)
$3.00B(+4.0%)
Jun 1991
-
$814.30M(+13.0%)
$2.89B(+4.2%)
Mar 1991
-
$720.50M(+6.3%)
$2.77B(+4.4%)
Dec 1990
$2.65B(+18.6%)
$678.10M(+0.6%)
$2.65B(+5.0%)
Sep 1990
-
$673.80M(-3.3%)
$2.53B(+3.9%)
Jun 1990
-
$696.80M(+15.6%)
$2.43B(-26.8%)
Mar 1990
-
$602.70M(+9.1%)
$3.32B(-22.6%)
Dec 1989
$2.24B(+19.8%)
$552.40M(-4.7%)
$4.29B(+258.1%)
Sep 1989
-
$579.60M(-63.4%)
$1.20B(-42.6%)
Jun 1989
-
$1.59B(+0.9%)
$2.09B(+4.3%)
Mar 1989
-
$1.57B(-161.9%)
$2.00B(+7.2%)
Dec 1988
$1.87B(+36.3%)
-$2.54B(-272.8%)
$1.87B(-11.4%)
Sep 1988
-
$1.47B(-2.1%)
$2.11B(+8.3%)
Jun 1988
-
$1.50B(+4.4%)
$1.95B(+14.8%)
Mar 1988
-
$1.44B(-162.5%)
$1.69B(+23.8%)
Dec 1987
$1.37B(+31.5%)
-$2.30B(-275.9%)
$1.37B(-20.8%)
Sep 1987
-
$1.31B(+4.6%)
$1.73B(+17.1%)
Jun 1987
-
$1.25B(+12.4%)
$1.48B(+19.8%)
Mar 1987
-
$1.11B(-157.3%)
$1.23B(+18.2%)
Dec 1986
$1.04B(+24.0%)
-$1.94B(-284.0%)
$1.04B(-15.4%)
Sep 1986
-
$1.05B(+4.8%)
$1.23B(+19.2%)
Jun 1986
-
$1.00B(+9.1%)
$1.03B(+14.1%)
Mar 1986
-
$921.10M(-152.6%)
$904.60M(+7.7%)
Dec 1985
$839.80M(+5.4%)
-$1.75B(-304.5%)
$839.80M(+6.5%)
Sep 1985
-
$855.80M(-2.5%)
$788.50M(-0.3%)
Jun 1985
-
$877.40M(+2.5%)
$790.60M(-1.7%)
Mar 1985
-
$856.30M(-147.5%)
$804.50M(+1.0%)
Dec 1984
$796.70M
-$1.80B(-309.9%)
$796.80M(-69.3%)
Sep 1984
-
$857.90M(-3.7%)
$2.60B(+49.3%)
Jun 1984
-
$891.30M(+5.0%)
$1.74B(+105.0%)
Mar 1984
-
$848.60M
$848.60M

FAQ

  • What is Merck & Co annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Merck & Co?
  • What is Merck & Co annual EBIT year-on-year change?
  • What is Merck & Co quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Merck & Co?
  • What is Merck & Co quarterly EBIT year-on-year change?
  • What is Merck & Co TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Merck & Co?
  • What is Merck & Co TTM EBIT year-on-year change?

What is Merck & Co annual earnings before interest & taxes?

The current annual EBIT of MRK is $20.22B

What is the all time high annual EBIT for Merck & Co?

Merck & Co all-time high annual earnings before interest & taxes is $20.22B

What is Merck & Co annual EBIT year-on-year change?

Over the past year, MRK annual earnings before interest & taxes has changed by +$17.19B (+566.26%)

What is Merck & Co quarterly earnings before interest & taxes?

The current quarterly EBIT of MRK is $4.35B

What is the all time high quarterly EBIT for Merck & Co?

Merck & Co all-time high quarterly earnings before interest & taxes is $11.98B

What is Merck & Co quarterly EBIT year-on-year change?

Over the past year, MRK quarterly earnings before interest & taxes has changed by $0.00 (0.00%)

What is Merck & Co TTM earnings before interest & taxes?

The current TTM EBIT of MRK is $21.06B

What is the all time high TTM EBIT for Merck & Co?

Merck & Co all-time high TTM earnings before interest & taxes is $21.06B

What is Merck & Co TTM EBIT year-on-year change?

Over the past year, MRK TTM earnings before interest & taxes has changed by $0.00 (0.00%)
On this page